19556122

Source:http://linkedlifedata.com/resource/pubmed/id/19556122

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:19556122	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:19556122	lifeskim:mentions	umls-concept:C0045093	lld:lifeskim
pubmed-article:19556122	lifeskim:mentions	umls-concept:C1442162	lld:lifeskim
pubmed-article:19556122	lifeskim:mentions	umls-concept:C0205390	lld:lifeskim
pubmed-article:19556122	lifeskim:mentions	umls-concept:C1134564	lld:lifeskim
pubmed-article:19556122	lifeskim:mentions	umls-concept:C0201734	lld:lifeskim
pubmed-article:19556122	lifeskim:mentions	umls-concept:C1550718	lld:lifeskim
pubmed-article:19556122	pubmed:issue	14	lld:pubmed
pubmed-article:19556122	pubmed:dateCreated	2009-9-1	lld:pubmed
pubmed-article:19556122	pubmed:abstractText	This study was performed to assess the toxicities, the maximum-tolerated dose (MTD), the pharmacokinetics and the anti-tumour activity of gemcitabine given by 24-h hepatic arterial infusion (HAI).	lld:pubmed
pubmed-article:19556122	pubmed:language	eng	lld:pubmed
pubmed-article:19556122	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:19556122	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:19556122	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:19556122	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:19556122	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:19556122	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:19556122	pubmed:month	Sep	lld:pubmed
pubmed-article:19556122	pubmed:issn	1879-0852	lld:pubmed
pubmed-article:19556122	pubmed:author	pubmed-author:PetersG JGJ	lld:pubmed
pubmed-article:19556122	pubmed:author	pubmed-author:GiacconeGG	lld:pubmed
pubmed-article:19556122	pubmed:author	pubmed-author:van...	lld:pubmed
pubmed-article:19556122	pubmed:author	pubmed-author:van RielJ MJM	lld:pubmed
pubmed-article:19556122	pubmed:author	pubmed-author:RuyterRR	lld:pubmed
pubmed-article:19556122	pubmed:author	pubmed-author:LaanA CAC	lld:pubmed
pubmed-article:19556122	pubmed:author	pubmed-author:van den...	lld:pubmed
pubmed-article:19556122	pubmed:author	pubmed-author:HoneywellR...	lld:pubmed
pubmed-article:19556122	pubmed:author	pubmed-author:MammatasL HLH	lld:pubmed
pubmed-article:19556122	pubmed:issnType	Electronic	lld:pubmed
pubmed-article:19556122	pubmed:volume	45	lld:pubmed
pubmed-article:19556122	pubmed:owner	NLM	lld:pubmed
pubmed-article:19556122	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:19556122	pubmed:pagination	2519-27	lld:pubmed
pubmed-article:19556122	pubmed:meshHeading	pubmed-meshheading:19556122...	lld:pubmed
pubmed-article:19556122	pubmed:meshHeading	pubmed-meshheading:19556122...	lld:pubmed
pubmed-article:19556122	pubmed:meshHeading	pubmed-meshheading:19556122...	lld:pubmed
pubmed-article:19556122	pubmed:meshHeading	pubmed-meshheading:19556122...	lld:pubmed
pubmed-article:19556122	pubmed:meshHeading	pubmed-meshheading:19556122...	lld:pubmed
pubmed-article:19556122	pubmed:meshHeading	pubmed-meshheading:19556122...	lld:pubmed
pubmed-article:19556122	pubmed:meshHeading	pubmed-meshheading:19556122...	lld:pubmed
pubmed-article:19556122	pubmed:meshHeading	pubmed-meshheading:19556122...	lld:pubmed
pubmed-article:19556122	pubmed:meshHeading	pubmed-meshheading:19556122...	lld:pubmed
pubmed-article:19556122	pubmed:meshHeading	pubmed-meshheading:19556122...	lld:pubmed
pubmed-article:19556122	pubmed:meshHeading	pubmed-meshheading:19556122...	lld:pubmed
pubmed-article:19556122	pubmed:meshHeading	pubmed-meshheading:19556122...	lld:pubmed
pubmed-article:19556122	pubmed:meshHeading	pubmed-meshheading:19556122...	lld:pubmed
pubmed-article:19556122	pubmed:meshHeading	pubmed-meshheading:19556122...	lld:pubmed
pubmed-article:19556122	pubmed:meshHeading	pubmed-meshheading:19556122...	lld:pubmed
pubmed-article:19556122	pubmed:year	2009	lld:pubmed
pubmed-article:19556122	pubmed:articleTitle	A phase I and pharmacokinetic study of gemcitabine given by 24-h hepatic arterial infusion.	lld:pubmed
pubmed-article:19556122	pubmed:affiliation	Department of Medical Oncology, VU University Medical Center, de Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.	lld:pubmed
pubmed-article:19556122	pubmed:publicationType	Journal Article	lld:pubmed
pubmed-article:19556122	pubmed:publicationType	Clinical Trial, Phase I	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:19556122	lld:pubmed